Prognostic Significance of Residual Breast Disease and Axillary Node Involvement for Patients Who Had Primary Induction Chemotherapy for Advanced Breast Cancer-Reference-Cited by-同舟云学术

Prognostic Significance of Residual Breast Disease and Axillary Node Involvement for Patients Who Had Primary Induction Chemotherapy for Advanced Breast Cancer

Published:2006-04-12 Issue:6 Volume:13 Page:783-787
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Escobar Pedro F.,Patrick Rebecca J.,Rybicki Lisa A.,Hicks David,Weng David E.,Crowe Joseph P.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/ASO.2006.07.024.pdf

Reference28 articles.

1. Adair F, Berg J, Joubert L, Robbins GF. Long term follow-up of breast cancer patients: the 30-year report. Cancer 1996;33:1145–50

2. Hortobagyi GN. Comprehensive management of locally advanced breast cancer. Cancer 1990;66:1387–91

3. Bear HD. Indications for neoadjuvant chemotherapy for breast cancer. Semin Oncol 1998;25:3–12

4. Schwartz GF, Birchansky CA, Komarnicky LT, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 1994;73:362–9

5. Jakesz R. The ABCSG: comparison of pre- vs. postoperative chemotherapy in breast cancer patients—four-year results of Austrian Breast & Colorectal Cancer Study Group (ABCSG) trial 7 (abstract). Proc Am Soc Clin Oncol 2001;20:125

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response in axillary lymph nodes to neoadjuvant chemotherapy for breast cancers: correlation with breast response, pathologic features, and accuracy of radioactive seed localization;Breast Cancer Research and Treatment;2023-06-08

2. Review on Assessment of Response of Neo-Adjuvant Chemotherapy in Patients of Carcinoma Breast by High Frequency Ultrasound;Journal of Evolution of Medical and Dental Sciences;2020-12-21

3. Enhanced axillary assessment using intradermally injected microbubbles and contrast-enhanced ultrasound (CEUS) before neoadjuvant systemic therapy (NACT) identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant;Breast Cancer Research and Treatment;2020-10-07

4. Evaluation of Discordance in Primary Tumor and Lymph Node Response After Neoadjuvant Therapy in Breast Cancer;Clinical Breast Cancer;2018-04

5. Pathology of Neoadjuvant Therapeutic Response of Breast Carcinoma;Breast Pathology;2017